Company page

Valbiotis Sa

Valbiotis SA is a public company listed on the French market under the ticker ALVAL, with a market capitalization of approximately €32.56 million. The company focuses on the research and development of innovative nutritional solutions aimed at preventing and managing metabolic diseases. Valbiotis is committed to advancing its product pipeline through scientific validation and partnerships.